Hikma Pharmaceuticals PLC (LON:HIK)
1,650.00
+6.00 (0.36%)
Sep 29, 2025, 9:42 AM BST
Hikma Pharmaceuticals Employees
Hikma Pharmaceuticals had 9,500 employees as of December 31, 2024. The number of employees increased by 400 or 4.40% compared to the previous year.
Employees
9,500
Change (1Y)
400
Growth (1Y)
4.40%
Revenue / Employee
247.09K GBP
Profits / Employee
28.50K GBP
Market Cap
3.64B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
Oxford Nanopore Technologies | 1,382 |
Hikma Pharmaceuticals News
- 7 weeks ago - Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Pre Recorded Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Hikma Pharmaceuticals PLC 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 7 weeks ago - Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Q&A Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Hikma Pharmaceuticals tumbles after injectables margin outlook cut - Reuters
- 2 months ago - Hikma Pharmaceuticals: a quality compounder waiting for a catalyst - The Armchair Trader
- 3 months ago - Hikma receives FDA approval for TYZAVAN™ (Vancomycin Injection, USP) in the US - PRNewsWire
- 3 months ago - Hikma Pharmaceuticals to invest $1B by 2030 to expand US manufacturing, R&D - Seeking Alpha
- 3 months ago - Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines - PRNewsWire